Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-DOPA for Late Life Depression
NCT03761030Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2019
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing L-DOPA Arm with Placebo Arm (2 arms). Primary endpoint: Hamilton Rating Scale for Depression at 8 weeks. Started Jan 2019; status: terminated.
02
Drugs
levodopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03761030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03761030.